Table 6.
Variable | Value Mean survival in months ± SD | Value Mean survival in months ± SD | P value |
---|---|---|---|
Gender | male 175 ± 42 | female 57 ± 17 | 0.09 |
Nationality | Saudi 94 ± 17 | non-Saudi 111 ± 37 | 0.4 |
Impaired synthetic function at presentation | no 136 ± 32 | yes 6.6 ± 3.6 | 0.003 |
Liver fibrosis on biopsy | Stages 1 and 2 117 ± 21 | Stages 3 and 4 12 ± 4 | 0.35 |
Ursodeoxycholic acid | given 143 ± 33 | not given 1.5 ± 1.5 | 0.0001 |
All post-operative complications | yes 30 ± 7.8 | no 119 ± 36 | 0.4 |
Ascending cholangitis | yes 221 ± 23 | no 42 ± 16.7 | 0.01 |
Post-operative liver failure | yes 8 ± 2.5 | no 166 ± 37 | 0.004 |
P-values in bold are significant. SD, standard deviation.